Abstract
The genome of the SARS-CoV-2 coronavirus contains 29 proteins, of which 15 are nonstructural. Nsp10 and Nsp16 form a complex responsible for the capping of mRNA at the 5′ terminus. In the methylation reaction, S-adenosyl-L-methionine (SAM) serves as the donor of the methyl group that is transferred to Cap-0 at the first transcribed nucleotide to create Cap-1. The presence of Cap-1 makes viral RNAs mimic host transcripts and prevents their degradation by the innate immune system. To investigate the 2′-O methyltransferase activity of SARS-CoV-2 Nsp10/16, we applied fixed-target serial synchrotron crystallography (SSX), which allows for physiological temperature data collection from thousands of crystals, significantly reducing the X-ray dose while maintaining a biologically relevant temperature. We determined crystal structures of Nsp10/16 that revealed the states before and after the methylation reaction, for the first time illustrating coronavirus Nsp10/16 complexes with the m7GpppAm2′-O Cap-1 product. These structures provide important mechanistic insight and can be used to design small molecules that inhibit viral RNA maturation, making SARS-CoV-2 sensitive to the host innate response.
Introduction: The Viral Camouflage Mechanism
To survive and replicate within a human host, SARS-CoV-2 must evade the innate immune response. A primary strategy involves "capping" its genetic material (RNA) to mimic human mRNA. This chemical mask at the 5′ end of the viral transcript prevents detection and destruction by host sensors like RIG-I.
The enzyme responsible for the final, critical step of this camouflage is the Nsp16 methyltransferase, which functions in a complex with Nsp10. This complex transfers a methyl group from S-adenosyl-L-methionine (SAM) to the Cap-0 structure, resulting in Cap-1. While previous structural studies captured the "pre-reaction" state, the "post-reaction" state (the methylated Cap-1 structure) remained elusive due to the limitations of traditional crystallography.
Methodological Innovation: Room-Temperature SSX
Traditional X-ray crystallography typically requires freezing crystals to 100 K and subjects them to high radiation doses. These conditions can damage delicate reaction intermediates and fail to capture the molecular dynamics that occur at physiological temperatures. To overcome these hurdles, this study employed Fixed-target Serial Synchrotron Crystallography (SSX) at 297 K.
The "Stop-Motion" Approach
Instead of relying on a single large crystal, the researchers deposited thousands of microcrystals onto a specialized nylon mesh (ALEX holder). By scanning the X-ray beam across these crystals and taking only limited images per sample, they reduced the radiation dose to 0.12 MGy—a fraction of the 4.97 MGy typical in traditional methods. This low-dose approach was essential for preserving the methylated product, which proved highly sensitive to radiation damage.
In-Crystallo Reaction and Automated Processing
The methylation reaction was triggered within the crystals by adding the RNA substrate (Cap-0) and the methyl donor (SAM). The team utilized the Kanzus data pipeline and the Theta supercomputer at Argonne National Laboratory to process tens of thousands of diffraction images in near real-time, resulting in high-resolution 3D atomic structures (2.18 Å to 2.25 Å).
Key Structural Insights
The First Look at Cap-1
This research provides the first structural evidence of the Nsp10/16 complex bound to the final methylated product (m7GpppAm2′-O). The data reveals that the enzyme undergoes a "tightening" around the RNA cap upon binding, followed by a release mechanism once the methylation is complete.
Temperature-Dependent Dynamics
Comparing the room-temperature (297 K) structures to traditional cryogenic (100 K) structures revealed significant differences. At physiological temperatures, specific loops in the protein showed movements of up to 3.0 Å. These movements make the RNA binding groove more accessible, suggesting that frozen structures may lock the enzyme in a less biologically relevant conformation.
The Catalytic Tetrad
The high-resolution structures support a catalytic model involving a "tetrad" of amino acids: Lys46, Asp130, Lys170, and Glu203. These residues coordinate the transfer of the methyl group and manage the necessary proton shuffling to activate the reaction. Because this active site is 95% identical between SARS-CoV-1 and SARS-CoV-2, it represents a highly stable target for broad-spectrum antiviral drugs.
Conclusion and Future Directions
By capturing the "before" and "after" states of the viral capping reaction, this study provides a blueprint for drug discovery. The identified binding pockets for the RNA cap and the SAM donor are now high-priority targets for virtual screening and fragment-based design.
While these static snapshots offer vital insights, the absence of a magnesium ion in the active site suggests it may only bind transiently during the transition state. Future work involving time-resolved SSX—capturing images at microsecond intervals—will be necessary to watch the viral camouflage process unfold in real-time.
Summary updated